| Title : C5 variant is associated with decreased risk of coronary artery disease in outpatients with severe hypercholinesterasemia - Nagayama_2014_Int.J.Clin.Pharmacol.Ther_52_471 |
| Author(s) : Nagayama D , Murano T , Saiki A , Shirai K , Tatsuno I |
| Ref : Int J Clinical Pharmacology & Therapeutics , 52 :471 , 2014 |
| Abstract : Nagayama_2014_Int.J.Clin.Pharmacol.Ther_52_471 |
| ESTHER : Nagayama_2014_Int.J.Clin.Pharmacol.Ther_52_471 |
| PubMedSearch : Nagayama_2014_Int.J.Clin.Pharmacol.Ther_52_471 |
| PubMedID: 24755128 |
Nagayama D, Murano T, Saiki A, Shirai K, Tatsuno I (2014)
C5 variant is associated with decreased risk of coronary artery disease in outpatients with severe hypercholinesterasemia
Int J Clinical Pharmacology & Therapeutics
52 :471
Nagayama D, Murano T, Saiki A, Shirai K, Tatsuno I (2014)
Int J Clinical Pharmacology & Therapeutics
52 :471